Sue Farrington joined the PIF Board as Chair in 2014. Sue is currently Chief Executive of Scleroderma and Raynaud’s UK having recently led the merger of two charities. She has over 25 years’ experience in senior leadership roles, working across the private, public and voluntary sector.
Sue is a strategic marketing and communications professional with a background in broadcast journalism and a track record in building award-winning awareness and change campaigns. Sue sits on the Board of the RAIRDA, a partnership established in 2016 to improve the quality of life of people living with rare autoimmune rheumatic diseases. Sue is a member of the UCL Partners Academic Health Science Centre Infection, Immunity and Inflammation Patient and Public Advisory Group.